Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14694299 | 0.78 | ALDH1A1 (0.34) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL19417367 | 0.75 | ALDH1A1 (0.32) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL221825 | 0.74 | SLC9A1 (0.41) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL11480635 | 0.73 | ADORA2A (0.36) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL25979874 | 0.73 | ADORA2A (0.36) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL2078821 | 0.73 | ADORA2A (0.36) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL11301702 | 0.73 | ALDH1A1 (0.37) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL16652006 | 0.73 | ADORA2A (0.36) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL2887322 | 0.73 | ALDH1A1 (0.37) | ALDH1A1LMNAMAPTTSHRPMP22 | |
| SCHEMBL12657637 | 0.72 | ADORA2A (0.41) | ALDH1A1LMNAMAPTTSHRPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695232-A1 | COMPOUNDS AND PROCESSES RELATED TO FLUMETYLSULFORIM | ADAMA MAKHTESHIM LTD. (IL) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024214047-A9 | COMPOUNDS AND PROCESSES RELATED TO FLUMETHYLSULFORIM | ADAMA MAKHTESHIM LTD. (IL) | 2025-05-30 | — | — | WO | disclosed |
| CN-119662655-A | Application of RNA molecule and composition thereof in tumor immunotherapy | 武汉厚先生物医药有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2024214047-A1 | COMPOUNDS AND PROCESSES RELATED TO FLUMETHYLSULFORIM | ADAMA MAKHTESHIM LTD. (IL) | 2024-10-17 | — | — | WO | disclosed |
| CN-117136182-A | Cationic lipids based on \"God\" buffers | 翻译生物公司 | 2023-11-28 | — | — | CN | disclosed |
| WO-2023220428-A1 | COMPOSITIONS FOR EDITING ASS1 TRANSCRIPTS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220440-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-16 | — | — | WO | disclosed |
| US-11795138-B2 | Process of fluorinating inorganic compounds by direct fluorination | Fujian Yongjing Technology Co.,Ltd (CN) | 2023-10-24 | — | — | US | disclosed |
| US-11795138-B2 | Process of fluorinating inorganic compounds by direct fluorination | Fujian Yongjing Technology Co.,Ltd (CN) | 2023-10-24 | — | — | US | disclosed |
| CN-116916936-A | Compositions and methods for delivering RNA | 再生技术有限责任公司 | 2023-10-20 | — | — | CN | disclosed |
| US-9580553-B2 | Thermally-activated self-immolative materials | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2017-02-28 | — | — | US | disclosed |
| US-9551724-B2 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL, INC. (US) | 2017-01-24 | — | — | US | disclosed |
| US-20160152573-A1 | BIOORTHOGONAL METHODS AND COMPOUNDS | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2016-06-02 | — | — | US | disclosed |
| US-20150368403-A1 | THERMALLY-ACTIVATED SELF-IMMOLATIVE MATERIALS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2015-12-24 | — | — | US | disclosed |
| EP-2280281-B1 | 5-fluoro-uracil immunoassay | SALADAX BIOMEDICAL INC (US) | 2014-05-21 | — | — | EP | disclosed |
| WO-2013178545-A1 | ACID CERAMIDASE INHIBITORS AND THEIR USE AS MEDICAMENTS | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2013-12-05 | — | — | WO | disclosed |
| EP-1846763-B1 | 5-FLUORO-URACIL IMMUNOASSAY | SALADAX BIOMEDICAL INC (US) | 2012-12-05 | — | — | EP | disclosed |
| EP-0502690-A2 | Cyclopropane derivative | Ajinomoto Co., Inc. (JP) | 1992-09-09 | — | — | EP | disclosed |
| US-4939156-A | Antitumor agents | MEIJI SEIKA KAISHA, LTD. (JP) | 1990-07-03 | — | — | US | disclosed |
| EP-0299413-A1 | New tetramethyl-cis-diaza-bicyclo[4.2.0]octane-3,5-dione derivatives having a differentiation-inducing activity | MEIJI SEIKA KAISHA LTD. (JP) | 1989-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368403-A1 | THERMALLY-ACTIVATED SELF-IMMOLATIVE MATERIALS | PARG, PAICS, LRBA | ALDH1A1 2098/4885LMNA 1599/4885MAPT 215/4885 |
| US-11795138-B2 | Process of fluorinating inorganic compounds by direct fluorination | AFF2, CYP4F2, AFF1 | ALDH1A1 1237/4885LMNA 4746/4885MAPT 3100/4885 |
| US-20160152573-A1 | BIOORTHOGONAL METHODS AND COMPOUNDS | DDT, DPYD, DNPEP | ALDH1A1 735/4885LMNA 3530/4885MAPT 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.